Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._

Abstract Background Randomized, placebo-controlled clinical trials (RCTs) that include analytical treatment interruptions (ATI) are conducted to test the efficacy of HIV cure strategies. Two independent RCTs, AELIX-002 and AELIX-003, evaluated the HTI immunogen-based vaccines alone or combined with...

Descripció completa

Dades bibliogràfiques

Autors principals:	Lucia Bailón, Yovaninna Alarcón-Soto, José R. Arribas, Adrian Curran, Anuska Llano, Samandhy Cedeño, Roger Paredes, Elena Vendrame, Devi SenGupta, Jeffrey J. Wallin, Romas Geleziunas, Marie P. Malice, Ian McGowan, Christian Brander, José Moltó, Beatriz Mothe
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-12-01
Col·lecció:	Communications Medicine
Accés en línia:	https://doi.org/10.1038/s43856-025-01266-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!